-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biora Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
- Biora Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$75K, a 122% decline from 2022.
- Biora Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $347K.
- Biora Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$119K, a 243% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)